MedTech Roundup

The Novasyte team is looking forward to connecting with the many healthcare industry leaders and our client partners in attendance at The MedTech Conference, powered by AdvaMed. The conference will be held on Monday, September 24th through Wednesday, September 26th at the Pennsylvania Convention Center. 

Topics: Novasyte News, Novasyte Partnership, Medical Device Industry

Novasyte is proud to welcome its newest member of the corporate team, Alycia Obregon, who officially started in her role of Travel and Expense Coordinator on Monday, July 9th.

Learn more about Alycia with her Q&A session below.

Topics: Novasyte News, Novasyte Growth

For patients with diabetes, the challenge of managing their therapy can be alleviated with proper, quality education. For more than a decade, Novasyte has partnered with many of the largest, global medical device, diagnostic, and pharmaceutical organizations, providing specialized education with the highest-quality certified product trainers.

Topics: Novasyte News, Med-Tech Industry Update, Medical Device Industry, San Diego, CA, Industry Trends

Novasyte is honored to announce that we ranked 1,692 overall and 125 in the healthcare category on the 2018 Inc. 5000 List of Fastest-Growing Private Companies in America. This marks the sixth consecutive year achieving this recognition, putting us on an exclusive short list of only six percent of companies acknowledged for maintaining this level of continued growth over the years, including Microsoft, Timberland, Vizio, Intuit, Chobani, Oracle and Zappos.com. 

Topics: Novasyte News, Business Awards, Novasyte Growth, Leadership News, Medical Device Industry, San Diego, CA, Pharmaceutical Industry

With increased pressures to reduce internal SG&A costs, accelerate the pace of business, and increase process efficacies, manufacturers are continually investing in third-party partnerships where innovation is at the forefront of service delivery.

Topics: Medical Device Recall Help, Med-Tech Industry Update, Medical Device Industry, Industry Trends, Industry Advancements, White Paper

The MedTech Tndustry is no stranger to change. 

Increasing customer demands coupled with reduced budgets, higher targets and new technologies are requiring organizations to think differently and pivot seamlessly — all while balancing risk.

A new challenge the MedTech industry is facing is how to plan for the aging workforce crisis among field service engineers.

Topics: Field Technical

Novasyte is proud to welcome its newest member of the corporate team, Odessa Woodburn, who officially started in her role of Travel and Expense Coordinator on Monday, July 9th.

Learn more about Odessa with her Q&A session below.

Topics: Novasyte News, Novasyte Growth

Novasyte is proud to welcome its newest member of the corporate team, Joshua Hogan, who officially started in his role of Healthcare Recruiter on Monday, July 9th.

Learn more about Joshua with his Q&A session below.

Topics: Novasyte News, Novasyte Growth

Improving the patient experience and measuring their satisfaction is becoming increasingly
important to facilities and manufacturers. Not only is patient satisfaction one of the three essential dimensions of the Institute for Health Improvement (IHI) Triple Aim, but the scores are also key performance metrics under the 2016 Center for Medicare and Medicaid Services (CMS) Hospital Value-Based Purchasing (VBP) Program.

Topics: Medical Device Recall Help, Med-Tech Industry Update, Medical Device Industry, Industry Trends, Industry Advancements, White Paper

Pharmaceutical manufacturers today are facing increasing pressures from The Trump Administration to reduce the cost of drug prices.

Announced on Wednesday of this week, Novartis indicated they would not be raising prices on its products for the remainder of 2018.¹ They are joining Pfizer, whose chief executive officer, Ian Read, announced on July 10 that the company would delay increasing the prices on dozens of drug products until 2019, following President Trump publicly spotlighting the firm the day prior.²

This follows the initial statement from The Trump Administration in May 2018 regarding a comprehensive blueprint strategy to lower drug prices.

Topics: Industry Trends, Pharmaceutical Industry